Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_assertion description "[Experience with these agents in patients with refractory anemia with excess blasts in transformation (reclassified by the World Health Organization as AML) was also reported in the clinical trials submitted to the FDA for approval of azacitidine for MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_assertion evidence source_evidence_literature NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_assertion SIO_000772 16341239 NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_assertion wasDerivedFrom befree-20150227 NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_assertion wasGeneratedBy ECO_0000203 NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP914129.RAucpSz1DcAtvTjbk05XFUQKa9-BOeNTzE3dOOEhusjuk130_provenance.